USDA, ARS, National Laboratory for Agriculture and the Environment , Ames, IA , USA.
USDA, ARS, National Animal Disease Center , Ames, IA , USA.
Front Vet Sci. 2014 Oct 9;1:9. doi: 10.3389/fvets.2014.00009. eCollection 2014.
Swine are often asymptomatic carriers of Salmonella spp., and interventions are needed to limit colonization of swine to enhance food safety and reduce environmental contamination. We evaluated the attenuation and potential vaccine use in pigs of a Salmonella enterica serovar Typhimurium mutant of rfaH, the gene encoding the RfaH antiterminator that prevents premature termination of long mRNA transcripts. Pigs inoculated with wild-type S. Typhimurium exhibited a significant elevation in average body temperature (fever) at 1 and 2 days post-inoculation; rfaH-inoculated pigs did not (n = 5/group). During the 7-day trial, a significant reduction of Salmonella in the feces, tonsils, and cecum were observed in the rfaH-inoculated pigs compared to wild-type inoculated pigs. To determine whether vaccination with the rfaH mutant could provide protection against wild-type S. Typhimurium challenge, two groups of pigs (n = 14/group) were intranasally inoculated with either the rfaH mutant or a PBS placebo at 6 and 8 weeks of age and challenged with the parental, wild-type S. Typhimurium at 11 weeks of age. The average body temperature was significantly elevated in the mock-vaccinated pigs at 1 and 2 days post-challenge, but not in the rfaH-vaccinated pigs. Fecal shedding at 2 and 3 days post-challenge and colonization of intestinal tract tissues at 7 days post-challenge by wild-type S. Typhimurium was significantly reduced in the rfaH-vaccinated pigs compared to mock-vaccinated pigs. Serological analysis using the IDEXX HerdChek Swine Salmonella Test Kit indicated that vaccination with the rfaH mutant did not stimulate an immune response against LPS. These results indicate that vaccination of swine with the attenuated rfaH mutant confers protection against challenge with virulent S. Typhimurium but does not interfere with herd level monitoring for Salmonella spp., thereby allowing for differentiation of infected from vaccinated animals (DIVA).
猪通常是沙门氏菌属的无症状携带者,需要采取干预措施来限制猪的定植,以增强食品安全和减少环境污染。我们评估了沙门氏菌肠亚种 Typhimurium rfaH 基因缺失突变体在猪体内的衰减和潜在疫苗用途,rfaH 基因编码的 RfaH 终止子抗转录物过早终止。接种野生型 S. Typhimurium 的猪在接种后 1 天和 2 天体温(发热)显著升高;而 rfaH 接种的猪则没有(每组 5 只)。在 7 天的试验中,与野生型接种猪相比,rfaH 接种猪粪便、扁桃体和盲肠中的沙门氏菌显著减少。为了确定 rfaH 突变体疫苗接种是否能提供针对野生型 S. Typhimurium 攻毒的保护,两组猪(每组 14 只)分别在 6 周龄和 8 周龄时经鼻腔接种 rfaH 突变体或 PBS 安慰剂,然后在 11 周龄时用亲本、野生型 S. Typhimurium 攻毒。攻毒后 1 天和 2 天,模拟接种猪的平均体温显著升高,但 rfaH 接种猪的体温则没有升高。攻毒后 2 天和 3 天粪便脱落,攻毒后 7 天野生型 S. Typhimurium 在肠道组织中的定植均显著减少rfaH 接种猪比模拟接种猪。使用 IDEXX HerdChek 猪沙门氏菌检测试剂盒进行血清学分析表明,rfaH 突变体疫苗接种不会刺激针对 LPS 的免疫反应。这些结果表明,用减毒 rfaH 突变体对猪进行疫苗接种可提供针对强毒 S. Typhimurium 攻毒的保护,但不干扰针对沙门氏菌属的群体水平监测,从而允许对感染动物和接种动物进行区分(DIVA)。